Boston Scientific Bid For New Stent Trial Rejected

Law360, New York (July 9, 2008, 12:00 AM EDT) -- A federal judge flatly denied Boston Scientific Corp.’s bids for a new trial Wednesday and let stand the court’s $501 million award to a radiologist who accused the medical device giant of infringing his patented drug-eluting stent.

Judge T. John Ward of the U.S. District Court for the Eastern District of Texas rejected Boston Scientific’s argument that the trial was marred by faulty claim construction and unfair testimony. The company had asked for a new trial unless Dr. Bruce N. Saffran accepted a remitted damages award...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.